Hide Studies Not Open or Pending
Condition(s):Medulloblastoma; Astrocytoma, Grade III; Glioblastoma; Anaplastic Astrocytoma; Brain Stem Neoplasms, Malignant; Oligodendroblastoma; Anaplastic Oligodendroglioma; Malignant GliomaLast Updated:June 23, 2022Completed
Condition(s):HydrocephalusLast Updated:February 5, 2016Completed
Condition(s):Glioma; Brain Cancer; Brain Tumor; Glioblastoma Multiforme; High Grade GliomaLast Updated:March 10, 2017Terminated
Condition(s):Brain TumorsLast Updated:October 29, 2012Completed
Condition(s):Brain Tumor; Low Grade Glioma; Astrocytoma; Ependymoma; GangliogliomaLast Updated:January 9, 2023Active, not recruiting
Condition(s):Central Nervous System TumorsLast Updated:June 10, 2022Completed
Condition(s):Malignant Glioma; Recurrent EpendymomaLast Updated:November 2, 2021Completed
Condition(s):Glioma; Pilocytic Astrocytoma; Anaplastic Astrocytoma; Glioblastoma; Mixed Oligoastrocytoma; Mixed Glioma; Oligodendroglioma; Optic Glioma; AstrocytomaLast Updated:January 31, 2023Recruiting
Condition(s):Sleep; FatigueLast Updated:August 19, 2019Completed
Condition(s):Recurrent Medulloblastoma; Recurrent Brain Tumor, Childhood; Malignant GliomaLast Updated:May 18, 2023Active, not recruiting
At TrialBulletin.com, we keep tabs on over 200,000 clinical trials in the US and abroad, using medical data supplied directly by the US National Institutes of Health. Please see the About and Contact page for details.